Chambers & Partners rankings 2019
06
Nov
2018
Carpmaels & Ransford recognised as a leading firm for the 12th consecutive year

We are delighted to announce that we have once again been listed in Band 1 for patent and trade mark attorneys in the latest edition of Chambers & Partners rankings. Five of our partners have also received individual recognition.

What the team is known for

Chambers says: “All-encompassing patent, trade mark and designs offering with expertise in biotechnology, chemicals, computer science, engineering and pharmaceuticals. Handles commercially sensitive EPO proceedings and also advises on the IP aspects of M&A deals and licensing agreements. Also has a powerful in-house patent litigation capability. Has an office in Munich.”

“A powerful patent litigation practice built on the solid foundations of one of the country’s leading patent attorney firms. The team draws on deep wells of knowledge across all conceivable scientific disciplines but has particularly cut a dash in life sciences.”

Strengths

“Carpmaels is an outstanding firm, by far the best I have worked with in terms of strategic vision and results achieved.”

“They are an excellent team of knowledgeable individuals who provide clear and timely advice.”

“They take a very team-focused approach to litigation – they don’t take any one lawyer for granted and welcome discussion.”

Individuals recognised by Chambers & Partners include: 

Hugh Goodfellow leads the life sciences practice, and has particularly authoritative knowledge with regard to stem cells, transgenics and immunology. Recent instructions have concerned the scope of Supplementary Protection Certificates (SPCs) in relation to second medical use.

Cameron Marshall ‘s focus lies in biotechnology and pharmaceuticals, and he is well versed in interferences and re-examinations in the USA as well as UK and EU registry procedure. Sources say he has “great business acumen and a strategic mind.”

Ian Kirby leads the firm’s patent litigation arm. A client says: “He creates an atmosphere of trust, he presents challenging ideas and is a good communicator.”

David Wilson qualified as a barrister prior to becoming a solicitor and is highly sought after for his experience leading complex, often multi-jurisdictional patent litigation campaigns. He is frequently instructed by innovators in pharmaceuticals and life sciences.

Camilla Balleny is a life sciences and pharmaceutical patents specialist who is called on to advise on the protection of rights at all stages, from filing through to litigation. She is a noted expert on SPCs.